AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05075720 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Meat without added nitrate
Description: The intervention comprises 65 g Pork mince on white bread sandwich at breakfast and lunch. Nitrate is not an allowed additive in pork mince.~This intervention will allow us to determine if there is endogenous formation of N-nitrosamines as well as N-nitrosamines present in the prepared meat due to the natural content of nitrate in meat.
Study NCT05075720 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Control
Description: The control comprises low nitrate vegetable protein burger on white bread. Protein content matched to interventions 1 and 2.
Study NCT05845489 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clopidogrel treatment group
Description: Patients assigned to the clopidogrel treatment group will maintain clopidogrel 75mg once a day for at least 5 years.
Study NCT05845489 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No antiplatelet or anticoagulant group
Description: Patients assigned to the no antiplatelet or anticoagulant group will not prescribe antithrombotics for at least 5 years. However, when there is a medical need for antithrombotic therapy during the follow-up, the prescription of antithrombotics is permitted with reporting to the research board.
Study NCT06404164 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Wedge resection under watershed analysis method
Description: * Compare the preoperative 3D reconstruction model, and use electrocautery to directionally separate and expose the target artery;~  * Auxiliary devices (unlimited) to block the target artery, but should not be severed; ③ Peripheral intravenous injection of ICG, electrocautery to mark the border of counter-staining; ④ Evaluate the actual incisal margin according to the preoperative planning, and use the cutting stapler to wedge resection of the pulmonary nodule
Study NCT05783648 — intervention group
Intervention type: DRUG
Intervention: Use of tranexamic acid
Description: Percentage of correct use according to POISE-3 criteria of tranexamic acid
Study NCT05019820 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Knee strengthening exercises with isokinetic dynamometer
Description: 18 sessions of strengthening exercises around the knee with an isokinetic dynamometer 3 days a week
Study NCT05019820 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Strengthening around the knees with home exercise programe
Description: 18 sessions of strengthening exercises for the muscles around the knee at home, 3 days a week
Study NCT05727917 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hetrombopag
Description: After hematopoietic stem cell reinfusion, the patients begin to take hetrombopag orally 7.5mg/d, until the patients reach complete platelet response.The treatment will stop when patients accept 21 consecutive days of treatment or reach the discontinuation criteria.
Study NCT05727917 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: After hematopoietic stem cell transfusion, the patients will be only observed, and the observation during the treatment period will be ended after 30 days
Study NCT05904691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OCU-10-C-110 for Injection
Description: OCU-10-C-110 for Injection in one of 3 doses
Study NCT04698655 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Recommendation from general practitioner
Description: Receive a hypothetical general practitioner recommendation for exercise
Study NCT04698655 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Information on osteoarthritis
Description: Asked to read 1 A4 page of brief information on osteoarthritis
Study NCT04698655 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Information on osteoarthritis
Description: Asked to read 1 A4 page of brief information on osteoarthritis
Study NCT04641065 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music listening
Description: An expert on the particular type of music will do the selection of the playlist of Traditional Turkish Military music, and this playlist will be listened to the patients by the researchers.
Study NCT05167604 — intervention group
Intervention type: DRUG
Intervention: Adjuvants, Pharmaceutic
Description: Patients with stage IB-IIA NSCLC after curative surgery were treated with adjuvant chemotherapy. The blood samples of the patients before and after adjuvant chemotherapy will be collected to examine the MRD status
Study NCT06132217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simmitinib
Description: Patients will oral administration according to study protocol until disease progression, death, unacceptable toxicity, loss of follow-up, withdrawal of consent or other conditions meet the end of treatment criteria.
Study NCT06132217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SG001
Description: Patients will receive intravenous infusion of SG001 according to study protocol until disease progression, unacceptable toxicity, meeting the suspension or termination criteria, or up to 24 months in patients without disease progression.
Study NCT05885191 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 2H intrinsically-labeled T.molitor with 13-C labeled amino acid mixture
Description: Test meal with dried 2H intrinsically labeled T.molitor and 13C labeled reference amino acid mixture will be divided into 10 portions, which will be given hourly over the course of 7 hours. The first consumption will be the priming meal, comprised of 3 portions and will additionally contain 13C sodium bicarbonate.
Study NCT04505293 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: InfraScanner 2000™
Description: The Infrascanner is a portable screening device that uses Near-Infrared (NIR) technology to screen patients for intracranial bleeding, identifying those who would most benefit from immediate referral to a CT scan and neurosurgical intervention.
Study NCT06156345 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Conservative with Denneroll
Description: Denneroll cervical traction orthodontic traction for 3 to 15 minutes once daily with conservative management of stretching and relaxation.
Study NCT06156345 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conservative
Description: conservative management of stretching and relaxation with placebo traction.
Study NCT06412263 — intervention group
Intervention type: PROCEDURE
Intervention: Routine root canal treatment/ retreatment
Description: It is a routine clinical procedure involving root canal treatment/ retreatment and pain assessment after the treatment
Study NCT06303973 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IOE
Description: The specific procedure was as follows: the infant was placed in a semi-recumbent or sitting position with the head fixed. Before each feeding, the infant's oral and nasal secretions were to be cleared. An intermittent oro-esophageal tube (Appendix) was appropriately lubricated with water on the head part. The professional medical staff held the tube and slowly inserted it through one side of the mouth into the upper part of the esophagus. The depth of insertion depended on the patient's age and height. After each feeding, the tube was immediately removed, and the patient was held upright for at least 30 minutes in case of reflux.
Study NCT06303973 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PNG
Description: In PNG group, disposable gastric tubes were used for feeding to provide nutritional support. Each feeding was administered by a nurse using the infant's mother's breast milk through the tube. The amount of each feeding varied from 20 to 100 ml depending on the age of the infant, with feedings given every 2 to 3 hours, approximately 10 times per day. The duration of each feeding procedure ranged from 10 to 20 minutes. The total daily intake ranged from 200 to 1000 ml. Each tube was kept indwelling for 5 to 7 days. When the tube needed to be replaced, it was removed after the last feeding of a day and a new tube was to be inserted through the other nostril on the following morning to continue the nutritional support.
Study NCT05878470 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: video
Description: A brief (119 seconds) social contact-based video. The video presented a young Black man in his early twenties, a professional actor, sharing his scripted personal story of struggles with psychotic illness and raising themes of recovery and hope.
Study NCT05655975 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: upper gi endoscopy
Description: In all patients undergoing RYGB gastric bypass, an upper gastrointestinal endoscopy will be performed at the 1st postoperative year to measure the diameter of the gastrojejunostomy anastomosis.
Study NCT06014307 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet order: PBMA, Animal
Description: Participants will follow the PBMA, and Animal diets (in this order) for 4-6 weeks each.
Study NCT06014307 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet order: Animal, PBMA
Description: Participants will follow the Animal, and PBMA diets (in this order) for 4-6 weeks each.
Study NCT04032925 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PICSO
Description: PICSO therapy is delivered through the PICSO Impulse System, which consists of the PICSO Impulse console and PICSO impulse catheter. The PICSO therapy is delivered in each patient for a minimum of 20 minutes to a maximum of 45 minutes.~The PICSO Impulse catheter is automatically activated by the PICSO Impulse console. It is inserted in the coronary sinus via femoral vein access. The PICSO Impulse Console cyclically inflates and deflates the balloon at the tip of the PICSO Impulse catheter, generating transient increase in coronary sinus pressure.
Study NCT05144672 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory tests
Description: Fasting blood glucose (FBG), postprandial blood glucose, total cholesterol (CHO), triglycerides (TG), high-density lipoprotein cholesterol and low-density lipoprotein cholesterol (LDL-C), urea, creatinine, and uric acid by point colorimetric assay.~Serum irisin.
Study NCT05144672 — intervention group
Intervention type: OTHER
Intervention: Anthropometric measurements
Description: Height, weight, waist circumference, and hip circumference were taken as a way of assessing the nutritional status and BMI
Study NCT05144672 — intervention group
Intervention type: PROCEDURE
Intervention: Electrocardiogram and Fundus examination
Description: Fundus examination by direct ophthalmoscope
Study NCT05144672 — intervention group
Intervention type: OTHER
Intervention: Estimated glomerular filtration rate (eGFR)
Description: Estimated glomerular filtration rate (eGFR) was calculated by EPI equation.
Study NCT05144672 — intervention group
Intervention type: OTHER
Intervention: Brachial index
Description: The ankle-brachial index test compares the blood pressure measured at your ankle with the blood pressure measured at your arm
Study NCT05144672 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory tests
Description: Glycosylated haemoglobin. ACR,urinary albumin (mg) and creatinine (g).
Study NCT05144672 — intervention group
Intervention type: RADIATION
Intervention: Abdominal ultrasound.
Description: It will be performed for patients only.
Study NCT05827705 — intervention group
Intervention type: OTHER
Intervention: need for Ephedrine hydrochloride
Description: ephedrine dose in hypotension
Study NCT06028698 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Inducing positive emotion music
Description: listening to music could induce emotion response, this study is going to investigate inducing positive emotion music countering mental fatigue.
Study NCT06028698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inducing positive emotion music
Description: listening to music could induce emotion response, this study is going to investigate inducing positive emotion music countering mental fatigue.
Study NCT04729348 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Oral, daily, dosage per protocol
Study NCT04729348 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Oral, daily, dosage per protocol
Study NCT05778994 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: INTORUS
Description: Exercise protocol with intorus
Study NCT05953298 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical impedance tomography (EIT)
Description: Electrical impedance tomography (EIT) is a non-invasive evaluation tool, without radiation, simple to set up at the patient's bedside and validated, making it possible to monitor the distribution of ventilation and lung recruitment with high temporal resolution, dynamic way and at a regional level
Study NCT05243628 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Afrezza (insulin human) Inhalation Powder
Description: Pharmaceutical form: powder~Route of administration: inhalation
Study NCT05243628 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: insulin degludec
Description: Pharmaceutical form: solution for injection~Route of administration: subcutaneous
Study NCT05243628 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Subcutaneous Insulin Infusion (CSII) pump with Automatic Insulin Delivery (AID)
Description: Acceptable AID systems in this study are Medtronic 670G/770G and Tandem Control IQ
Study NCT05243628 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Subcutaneous Insulin Infusion (CSII) pump with Automatic Insulin Delivery (AID)
Description: Acceptable AID systems in this study are Medtronic 670G/770G and Tandem Control IQ
Study NCT05726331 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chiropractic Care
Description: Chiropractic care will be delivered by community-based chiropractors that meet pre-set qualifications. Chiropractic treatment protocol will be multimodal and will follow predefined standard operating procedures including the following 6 components: 1) Posture correction and spinal stabilization exercises; 2) Soft tissue release techniques; 3) Manual spinal manipulation; 4) Condition-specific education; 5) Myofascial strengthening and motor control training; 6) Ergonomic and lifestyle modifications/advice. Subjects randomized to chiropractic treatment groups will receive up to 10 chiropractic sessions over 16 weeks.
Study NCT05726331 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Chiropractic Care
Description: Chiropractic care will be delivered by community-based chiropractors that meet pre-set qualifications. Chiropractic treatment protocol will be multimodal and will follow predefined standard operating procedures including the following 6 components: 1) Posture correction and spinal stabilization exercises; 2) Soft tissue release techniques; 3) Manual spinal manipulation; 4) Condition-specific education; 5) Myofascial strengthening and motor control training; 6) Ergonomic and lifestyle modifications/advice. Subjects randomized to chiropractic treatment groups will receive up to 10 chiropractic sessions over 16 weeks.
Study NCT05726331 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tai Chi
Description: Tai Chi (TC) will be delivered by community based Tai Chi schools that meet pre-set qualifications. TC programs will emphasize core principles including biomechanically efficient alignment, relaxed integrated movements, deep breathing, and heightened body awareness. Subjects randomized to TC treatment group will attend at least one TC class per week for 16 weeks.
Study NCT05726331 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced Usual Care
Description: Enhanced Usual Care will include educational materials about neck pain provided by the study, in addition to usual medical care for CNNP. Usual care for CNNP generally includes medications (non-narcotic analgesics, NSAIDs, muscle relaxants), interventional pain management (e.g., steroid injections), and self-care exercises (all of which will be monitored and recorded in all three study arms).
Study NCT06400862 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: eOCT implantation
Description: eOCT is regarded as an Advanced Therapy Product (ATP).
Study NCT05262127 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Flash Version of EMDR
Description: EMDR and the inclusion of a positive engaging focus generated autonomously by participant
Study NCT05726331 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Enhanced Usual Care will include educational materials about neck pain provided by the study, in addition to usual medical care for CNNP. Usual care for CNNP generally includes medications (non-narcotic analgesics, NSAIDs, muscle relaxants), interventional pain management (e.g., steroid injections), and self-care exercises (all of which will be monitored and recorded in all three study arms).
Study NCT04982705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [Part 1.1] IDG-16177
Description: \[Part 1.1\] Subjects will receive a single oral dose of IMP. Dose strenght for each cohort (Cohort 1-5) is planned as 0.5, 1, 2, 5, 10mg, respectively.
Study NCT04982705 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: [Part 1.1] Placebo of IDG-16177
Description: \[Part 1.1\] subjects will receive a single oral dose of IMP.
Study NCT04982705 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: [Part 2] Sitagliptin
Description: Administration of Sitagliptin 100mg once daily for 4 weeks.
Study NCT04982705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [Part1.2] IDG-16177
Description: \[Part 1.2\] Administration once daily for 14 days; Dose strenght for each cohort (Cohort 6-8) is planned as ≤ 2, ≤ 4, ≤ 8mg, respectively.
Study NCT04982705 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [Part 2] IDG-16177
Description: \[Part 2\] Administration once daily for 4 weeks.
Study NCT04982705 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: [Part 1.2] Placebo of IDG-16177
Description: \[Part 1.2\] Administration once daily for 14 days.
Study NCT04982705 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: [Part 2] Placebo of IDG-16177
Description: \[Part 2\] Administration once daily for 4 weeks.
Study NCT04895930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: 80mg/day orally on a continuous dosing schedule. If subjects suffer from AEs, they can get declined dosage (40mg).
Study NCT04895930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib
Description: 10mg/day orally from day 1 to 14 of a 21-day cycle. If subjects suffer from AEs, they can get declined dosage (8mg).
Study NCT05096897 — intervention group
Intervention type: OTHER
Intervention: Self-administrated questionnaires
Description: GOHAI, IBD-Q, IBD-disk
Study NCT06522477 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality gait training
Description: Individuals will walk on a treadmill with overhead harness system in place while viewing 1st-person perspective walking videos on a television placed immediately in front of the treadmill.
Study NCT05480839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: M-IBCS
Description: Manual Cataract Surgery - Phacoemulsification: removal of the eye lens and insertion of an intraocular lens implant
Study NCT05480839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ReLA-IBCS Early
Description: Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery - ReLA-IBSCS with early administration of anesthesia
Study NCT05480839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ReLA-ISBCS
Description: Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery - ReLA-IBSCS with standard administration of anesthesia
Study NCT05432024 — intervention group
Intervention type: DEVICE
Intervention: Catheter ablation
Description: An ablation catheter is introduced in the heart. Ablation is performed by applying ablation energy to the target tissue. The aim of ablation is to create an ablation lesion that does not conduct the electrical signals that induce or sustain the cardiac arrhythmia.
Study NCT05576766 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Routine care
Description: 1. Routine information provided before surgery.~2. No nutritional therapy.~3. No aerobic exercise.~4. No pelvic floor muscle training.~5. No psychiatrist intervention.~6. Bowel preparation with oral cathartic agent.~7. Fasting for over 8 hours; no oral carbohydrate solution (OCS) loading before surgery.~8. Hypothermia prevention not emphasized.~9. General anesthesia; regional block not emphasized.~10. Routine blood pressure management.~11. Mobilization from postoperative day 1.~12. Start oral feeding from postoperative day 1.~13. Patient-controlled analgesia with opioids.~14. Thromboembolism prophylaxis with low-molecular-weight heparin (LMWH).~15. Routine pelvic drainage tube removal (usually at postoperative day 4).~16. Routine urinary catheterization removal (usually at postoperative day 14).
Study NCT05576766 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ERAS management pathway
Description: 1. Patient consultation and education before surgery.~2. Nutritional intervention for patients whose BMI\<18.5 or BMI>24 kg/m2.~3. Aerobic exercise for 2 weeks before surgery.~4. Pelvic floor muscle training for 2 weeks before surgery.~5. Psychiatrist intervention for patients with severe depression and anxiety.~6. No bowel preparation before surgery.~7. Provide oral carbohydrate solution 2 hours before surgery.~8. Hypothermia prevention.~9. General anesthesia combined with regional block.~10. Goal-directed fluid infusion and targeted blood pressure management.~11. Early mobilization.~12. Early oral feeding.~13. Multimodal analgesia, including opioids and non-steroid anti-inflammatory drugs.~14. Thromboembolism prophylaxis with low-molecular-weight heparin; rivaroxaban for high-risk patients.~15. Early pelvic drainage tube removal (at postoperative day 2) unless contraindicated.~16. Early urinary catheterization removal (at postoperative day 7) unless contraindicated.